Hello, You’ve asked for my story about T1D, so I decided to share it briefly with you all. I’ve been a military and civilian pilot for over 50 years. Each of those years, I’ve taken an FAA physical exam with normal results. My last exam was in November 2014, and my BG was 85. In… Continue reading Does Shingles Vaccine have T1D Side Effect?
Author: Martin Hensel
Martin is the Founder of SelfRx Media and editor-in-chief of Insulin Nation. He's a passionate about sharing knowledge with those affected by Diabetes.
Back-to-School Basics for Diabetes Care
It’s no surprise that many of our usual habits fall to the wayside during the summer months. Vacations, beach days, and day trips are interruptions to our normal routines, so getting back into the swing of things can be difficult for those who need to manage their health on a daily basis. Whether you are… Continue reading Back-to-School Basics for Diabetes Care
Making the Right Medicare Supplement Plan Choice
We spoke with Burt Kravitz about choosing Medicare Supplement plans. ‘Picking the right Part B Supplement plan is the most important decision you make when you begin Medicare. ‘You only get one chance to pick a plan where no physical exam is required. Thereafter, if you want to switch plans or start of a new… Continue reading Making the Right Medicare Supplement Plan Choice
Are High Insulin Prices Caused by the FDA Supply-limiting Regulation?
We spoke with Raymond March, Ph.D. who is a Faculty Fellow at the Center for the Study of Public Choice and Private Enterprise and Director of FDA Review — https://www.fdareview.org about how his type 1 diabetes influenced his decision to research healthcare economics and regulation. Dr. March joined the faculty of North Dakota State University… Continue reading Are High Insulin Prices Caused by the FDA Supply-limiting Regulation?
57 years with T1D; Nonetheless, the Future is Uncertain
We spoke with Michael Schrom who lives in Othello, Washington, a farming community in Eastern Washington, about his life with type 1 diabetes. “I was born in Ephrata and was living on a ranch near Smyrna when I was diagnosed in December of 1962. I was seven. At that time, the average life expectancy was… Continue reading 57 years with T1D; Nonetheless, the Future is Uncertain
My Pancreatic Cancer Journey and its Wonderful Outcome
Tumor Discovered “My tumor in my pancreas was discovered in February 2017 at Pronto Soccorso in Manduria Italy. I immediately flew to Sweden and was hospitalized at Karolinska/Huddinge Hospital in Stockholm. The news was not good. I was too old and the operation was too complicated according to most Swedish doctors. Search for Options Rather… Continue reading My Pancreatic Cancer Journey and its Wonderful Outcome
Lowering A1c is often an Endo problem
We spoke with Liz Meyer, the mom of a growing T1D boy who was diagnosed three years ago. Here is her story.* “I wish lowering A1c wasn’t as big of a problem as it is. I think the problem stems from doctors who still think in the ’80s. When my son was diagnosed just… Continue reading Lowering A1c is often an Endo problem
Painful Medicare Journey to get GGM/Pump Coverage
We spoke with Tom Linn an attorney in Colorado who was diagnosed with T1D at age 69, 3 years ago. This is his story. “My symptoms were classic yet I was first diagnosed as Type 2. My blood glucose never lowered and after 10 days with no improvement, my primary care doctor gave me a… Continue reading Painful Medicare Journey to get GGM/Pump Coverage
Shaheen Leads Senate Bipartisan Push to Rollback Over a Decade of Insulin Price Hikes
Senator Shaheen just introduced legislation to rollback insulin prices: Official Release The JDRF announced this support for the legislation “No one should suffer or die because they cannot access insulin. We are very grateful for Senators Shaheen, Collins, Carper, and Cramer for introducing this important piece of legislation, which would treat insulin like the life-saving drug… Continue reading Shaheen Leads Senate Bipartisan Push to Rollback Over a Decade of Insulin Price Hikes
IFNα Kinoid: A promising vaccine against Type 1 Diabetes
Neovacs — www.neovacs.fr — is a French biotech company focused on the development of Kinoids®, therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies, and cancer. They presented pre-clinical results for T1D its therapeutic vaccine, IFNα Kinoid, during an ADA poster session on June 9th in San Francisco. Dr. Noemie Caillot, PhD (Neovacs), presented… Continue reading IFNα Kinoid: A promising vaccine against Type 1 Diabetes
Blood glucose-dependent insulin delivery to simplify treatment
We corresponded with Jingqiang Wang and Professor Zhen Gu of UCLA Engineering about their research on glucose-responsive insulin analogs (ref). The goal of their research is a simple-to-administer system that delivers insulin in a blood glucose-dependent manner. Q1: Is subcutaneous injection the only delivery mechanism? R1: Subcutaneous injection is effective in this study and is… Continue reading Blood glucose-dependent insulin delivery to simplify treatment
Newly Diagnosed and Impressed with T1D Technology
We spoke with Leika Scott, age 22 and a 2018 graduate of Saint Anselm College Nursing School who self-diagnosed her diabetes in September. “I had the usual symptoms of Diabetes; polyuria (excessive urination) and polydipsia (excessive thirst). I remembered learning the typical signs and symptoms of Type 1 diabetes in nursing school and this felt… Continue reading Newly Diagnosed and Impressed with T1D Technology
Reader Correspondence
Should I get my son a pump Hello My son Abdo 15 Y old, has DM type 1 since Jan 2018, and he’s got vitiligo from about 3 years ago, his weight is about 43kg, and 163cm long, the types of insulin he injects are: Actrapid: -8u___10u____8u before meals. LANTUS: -16U at bedtime. The last… Continue reading Reader Correspondence
Auxulin: Hyperglycemic Innovation Driven by Need
We spoke with Tommy Ritz, MBA, and Dr. Jason McDevitt, William & Mary’s Tech Transfer Director about Auxulin – https://auxulin.com/ – the company they founded to market a new drug that alleviates hyperglycemic episodes. Tommy was diagnosed with Type 1 Diabetes (T1D) at age 5. “My dad Gary has been a diabetic since he was 25, so… Continue reading Auxulin: Hyperglycemic Innovation Driven by Need
Hillo to Remove Burden from your Life
We spoke with Stéphane Bidet, CEO of Hillo — http://hillo.ai. “Nicolas Caleca, CSO, and I founded this company to reduce the fear and unpredictability of managing T1D. “My wife has T1D and I see her struggles. She is fearful of the complications of hyperglycemia so she generally overdoses with insulin. Thus, she has… Continue reading Hillo to Remove Burden from your Life
Wearable Heart Monitor Detects T1D Hypoglycemia
We spoke with Mats Koeneman, MSc and Technical Physician with the REshape Center for Innovation at Radboud University Medical Center, The Netherlands — https://www.radboudumc.nl/reshape — who co-authored a recent study in Diabetes Journal to get his thoughts on how wearables might help people with T1D who are hypo unaware. Note: Technical Physician is a new… Continue reading Wearable Heart Monitor Detects T1D Hypoglycemia
MyGrams Simplifies Carb Counting
We spoke with Daniel Blumer, CEO of MyGrams — https://www.mygrams.com/ — about his food scale smartphone case and app. “I was diagnosed with T1D at 20 years,” said Daniel Blumer, CEO. “Even though you learn over time how many bread units and carbohydrates a food contains, this can become a major problem when trying… Continue reading MyGrams Simplifies Carb Counting
Metformin improves insulin sensitivity in overweight/obese adolescents with T1D
We spoke with Kristen Nadeau, MD, MS, (bio) Professor of Pediatrics and Research Director, Pediatric Endocrinology at the University of Colorado SOM about a study that was just published in The Journal of Clinical Endocrinology & Metabolism. Context “Type 1 diabetes for both normal weight and overweight adolescents is characterized by insulin deficiency and resistance… Continue reading Metformin improves insulin sensitivity in overweight/obese adolescents with T1D
Diasome’s Liver Targeted Insulin
We spoke with Robert Geho, CEO of Diasome Pharmaceuticals, Inc. — www.diasome.com — about its nanotechnology additive that delivers insulin to the liver where it can substantially improve T1D glucose control. Normal vs Injected Insulin In normal human physiology, the liver stores glucose at mealtime when insulin is released by the pancreas to prevent hyperglycemia… Continue reading Diasome’s Liver Targeted Insulin
Overnight Dosing Success in T1D Children
We spoke with Ulrike Schierloh, MD who is with the Pediatric Clinic, Centre Hospitalier de Luxembourg, Luxembourg, GD de Luxembourg about the study that was just published in PLOS|One. Study Overview This study obtained glucose levels as well as plasma insulin levels in children with type 1 diabetes to evaluate the efficacy of a model—based… Continue reading Overnight Dosing Success in T1D Children
